Literature DB >> 8196276

Tubular lipidosis: epiphenomenon or pathogenetic lesion in human renal disease?

A C Ong1, J F Moorhead.   

Abstract

Tubular lipidosis is a commonly observed histological lesion in proteinuric renal diseases. We have studied the interaction between native and modified human lipoproteins and human renal proximal tubular cells to investigate whether lipoproteins could be injurious to tubular cells in culture. Human renal proximal tubular cells were cultured and characterized by established methods. Preliminary studies showed that these cells could take up and degrade normal human lipoproteins by high affinity (HDL) and low affinity (LDL) pathways. In subconfluent culture, native lipoproteins, that is, LDL, HDL2 and HDL3, had markedly different effects on cell growth as measured by 3H-thymidine uptake and total cell protein as compared to modified lipoproteins such as minimally modified and oxidized LDL. In addition, we found that renal tubular cells could oxidized native LDL in the presence of copper largely by a superoxide-mediated mechanism. Finally, cellular accumulation of lipid was demonstrated in vitro by incubating cultured cells with varying lipoprotein concentrations for up to 48 hours. Notably, cell detachment was observed only with high concentrations of modified LDL especially with minimally modified LDL. We speculate that uptake and oxidation of filtered LDL by tubular cells may lead to tubular injury in nephrotic states.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8196276     DOI: 10.1038/ki.1994.100

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  4 in total

1.  Immunological evidence for hypochlorite-modified proteins in human kidney.

Authors:  E Malle; C Woenckhaus; G Waeg; H Esterbauer; E F Gröne; H J Gröne
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

2.  Scavenger receptor BI promotes cytoplasmic accumulation of lipoproteins in clear-cell renal cell carcinoma.

Authors:  Srividya Velagapudi; Peter Schraml; Mustafa Yalcinkaya; Hella A Bolck; Lucia Rohrer; Holger Moch; Arnold von Eckardstein
Journal:  J Lipid Res       Date:  2018-09-01       Impact factor: 5.922

3.  Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation.

Authors:  Paul O Schwille; A Schmiedl; J Wipplinger
Journal:  Eur J Med Res       Date:  2009-09-01       Impact factor: 2.175

Review 4.  Beneficial effect of LDL-apheresis in refractory nephrotic syndrome.

Authors:  Eri Muso
Journal:  Clin Exp Nephrol       Date:  2014-02-18       Impact factor: 2.801

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.